NCT01497145View on ClinicalTrials.gov

A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
MDS
Interventions
DRUG

KRN321

Trial Locations (2)

Unknown

Saitama

Seoul

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT01497145 - A Clinical Study of KRN321 in Adult Subjects With Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter